VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,031,000 | +4200.0% | 456,087 | +10110.1% | 0.04% | +2150.0% |
| Q1 2016 | $117,000 | -66.2% | 4,467 | +130.0% | 0.00% | -71.4% |
| Q3 2015 | $346,000 | -93.6% | 1,942 | -92.0% | 0.01% | -90.0% |
| Q2 2015 | $5,425,000 | +13.7% | 24,422 | +1.6% | 0.07% | +14.8% |
| Q1 2015 | $4,772,000 | +233.2% | 24,026 | +140.1% | 0.06% | +258.8% |
| Q4 2014 | $1,432,000 | +123.1% | 10,007 | +96.4% | 0.02% | +142.9% |
| Q2 2014 | $642,000 | -81.1% | 5,094 | -80.2% | 0.01% | -87.0% |
| Q1 2014 | $3,397,000 | +78.4% | 25,771 | +59.0% | 0.05% | +86.2% |
| Q4 2013 | $1,904,000 | +192.9% | 16,212 | +160.4% | 0.03% | +190.0% |
| Q3 2013 | $650,000 | – | 6,226 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |